Keisha Arnold, | |
1530 Breezeport Way Ste 100, Suffolk, VA 23435-3753 | |
(757) 394-1135 | |
(757) 282-7771 |
Full Name | Keisha Arnold |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 1530 Breezeport Way Ste 100, Suffolk, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073021234 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 0701007389 (Virginia) | Primary |
Entity Name | Gateway Medical & Mental Healthcare Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245827070 PECOS PAC ID: 3173912144 Enrollment ID: O20211112000244 |
News Archive
McDonald's is all set to introduce a ‘healthy' fizzy drink for children that promises one of their five-a-day portions of fruit and vegetables. However the drink is packed with sugar and calories.
The Stanford University School of Medicine will no longer accept support from pharmaceutical or device companies for specific programs in continuing medical education, as industry-directed funding may compromise the integrity of these education programs for practicing physicians, officials said.
Leptospirosis is a water-related bacterial disease with a high incidence in Southeast Asia. People usually become infected through exposure to water contaminated by the urine of infected animals, mainly rats and mice. In the framework of the CERoPath program, IRD researchers and their partners have revealed the relationship between rodents' environment and infection by leptospirosis bacteria.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported financial results for its third fiscal quarter ended March 31, 2010, and also announced progress in its late-stage clinical development programs and corporate operations.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Keisha Arnold, 3013 Tournament Dr, Chesapeake, VA 23323-2732 Ph: (757) 692-3013 | Keisha Arnold, 1530 Breezeport Way Ste 100, Suffolk, VA 23435-3753 Ph: (757) 394-1135 |
News Archive
McDonald's is all set to introduce a ‘healthy' fizzy drink for children that promises one of their five-a-day portions of fruit and vegetables. However the drink is packed with sugar and calories.
The Stanford University School of Medicine will no longer accept support from pharmaceutical or device companies for specific programs in continuing medical education, as industry-directed funding may compromise the integrity of these education programs for practicing physicians, officials said.
Leptospirosis is a water-related bacterial disease with a high incidence in Southeast Asia. People usually become infected through exposure to water contaminated by the urine of infected animals, mainly rats and mice. In the framework of the CERoPath program, IRD researchers and their partners have revealed the relationship between rodents' environment and infection by leptospirosis bacteria.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported financial results for its third fiscal quarter ended March 31, 2010, and also announced progress in its late-stage clinical development programs and corporate operations.
› Verified 1 days ago
Chaniece Winfield, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 135 S Saratoga St, Suffolk, VA 23434 Phone: 757-842-0542 | |
Megan Lea Johnson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 707 Gittings St Ste 120, Suffolk, VA 23434 Phone: 757-514-3248 | |
Hannah Alyse Andrews, Counselor Medicare: Not Enrolled in Medicare Practice Location: 318 Baron Blvd, Suffolk, VA 23435 Phone: 757-992-8910 | |
Satrina Artis, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1000 Commercial Ln, Suffolk, VA 23434 Phone: 757-925-2484 Fax: 757-925-2205 | |
Arielle Shipp, LPC, PMH-C Counselor Medicare: Not Enrolled in Medicare Practice Location: 109 Clay St, Suffolk, VA 23434 Phone: 757-965-8663 Fax: 757-539-8834 | |
Ashley Lynn Bianchini, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2790 Godwin Blvd Ste 210, Suffolk, VA 23434 Phone: 513-834-7063 | |
Mrs. Ashanti Courtney Conner, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7025 Harbour View Blvd Ste 119, Suffolk, VA 23435 Phone: 757-274-2836 Fax: 757-673-2586 |